CGA
DXR icon

Crescent Grove Advisors’s Daxor DXR Stock Holding History

Crescent Grove Advisors’s Portfolio DXR Stock Details DXR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$104K Buy
+10,723
New +$131K 0.01% 300

Other funds holding DXR

TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.7B AUM 6.69% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Aristides Capital Louisville, Kentucky $462M AUM 28.94% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EWM
Empirical Wealth Management Seattle, Washington $6.85B AUM 30.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $107M AUM
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

Crescent Grove Advisors's DXR Position: Q1 2026 in Review

Crescent Grove Advisors opened a new position in Daxor (DXR) in Q1 2026: 10,723 shares worth $104K. The stake represents 0.01% of the portfolio and ranks #300 among its holdings.

14 funds tracked by Wall St. Rank hold DXR as of Q1 2026.

  • Crescent Grove Advisors held 10,723 shares of Daxor worth $104K as of Q1 2026.
  • Daxor was a new Crescent Grove Advisors position in Q1 2026.
  • Daxor made up 0.01% of Crescent Grove Advisors's portfolio in Q1 2026, its #300 holding.
  • 14 funds tracked by Wall St. Rank held Daxor as of Q1 2026.

Based on Crescent Grove Advisors's 13F filing for Q1 2026, filed 6 May 2026.